Dynamic Technology Lab’s Aclaris Therapeutics ACRS Stock Holding History

Dynamic Technology Lab’s Portfolio ACRS Stock Details ACRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$72K	Buy	+13,521	New	+$60.3K	0.02%	607
2023 Q4	–	Sell	-14,135	Closed	-$97K	–	995
2023 Q3	$97K	Buy	+14,135	New	+$121K	0.01%	866
2022 Q1	–	Sell	-13,873	Closed	-$201K	–	1057
2021 Q4	$201K	Buy	+13,873	New	+$210K	0.02%	962
2021 Q3	–	Sell	-24,061	Closed	-$422K	–	1018
2021 Q2	$422K	Buy	+24,061	New	+$547K	0.04%	654
2018 Q2	–	Sell	-11,325	Closed	-$198K	–	944
2018 Q1	$198K	Buy	+11,325	New	+$240K	0.03%	901
2017 Q4	–	Sell	-12,729	Closed	-$328K	–	970
2017 Q3	$328K	Buy	+12,729	New	+$341K	0.05%	679
2017 Q1	–	Sell	-7,670	Closed	-$209K	–	936
2016 Q4	$209K	Buy	+7,670	New	+$196K	0.06%	703

Other funds holding ACRS

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

BCM

BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

FLSM

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return

Dynamic Technology Lab's ACRS Position: Q2 2026 in Review

Dynamic Technology Lab opened a new position in Aclaris Therapeutics (ACRS) in Q2 2026: 13,521 shares worth $72K. The stake represents 0.02% of the portfolio and ranks #607 among its holdings. This is a return to the name: Dynamic Technology Lab previously reported a position in ACRS as recently as Q3 2023.

Dynamic Technology Lab first reported a position in ACRS in Q4 2016 and has held it in 7 quarters since. The position peaked at $422K in Q2 2021. 149 funds tracked by Wall St. Rank hold ACRS as of Q2 2026.

Dynamic Technology Lab held 13,521 shares of Aclaris Therapeutics worth $72K as of Q2 2026.
Aclaris Therapeutics was a new Dynamic Technology Lab position in Q2 2026.
Aclaris Therapeutics made up 0.02% of Dynamic Technology Lab's portfolio in Q2 2026, its #607 holding.
Dynamic Technology Lab first reported a position in Aclaris Therapeutics in Q4 2016 and has held it in 7 quarters since.
Dynamic Technology Lab's Aclaris Therapeutics position peaked at $422K in Q2 2021.
149 funds tracked by Wall St. Rank held Aclaris Therapeutics as of Q2 2026.

Based on Dynamic Technology Lab's 13F filing for Q2 2026, filed 13 Aug 2026.